benzeneboronic acid and Liver Neoplasms
benzeneboronic acid has been researched along with Liver Neoplasms in 3 studies
Research
Studies (3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Chun, HJ; Hur, W; Kang, BY; Kim, S; Kim, SM; Kim, WJ; Lee, J; Tak, E; Yoon, SK | 1 |
| Han, H; Li, Q; Liu, Y; Shi, Z; Yang, J; Zhang, J | 1 |
| Chen, Y; Feng, P; Gu, Z; Hu, Q; Lu, Y; Qian, C; Shen, QD; Sun, W; Tang, X; Xiao, X; Yu, J; Zhang, L; Zhu, S | 1 |
Other Studies
3 other study(ies) available for benzeneboronic acid and Liver Neoplasms
| Article | Year |
|---|---|
Phenylboronic acid conjugated to doxorubicin nanocomplexes as an anti-cancer drug delivery system in hepatocellular carcinoma.
Topics: Animals; Antibiotics, Antineoplastic; Boronic Acids; Carcinoma, Hepatocellular; Cell Line, Tumor; Doxorubicin; Drug Delivery Systems; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred C57BL; Nanoconjugates; Xenograft Model Antitumor Assays | 2021 |
Phenylboronic acid-modified polyamidoamine-mediated delivery of short GC rich DNA for hepatocarcinoma gene therapy.
Topics: Animals; Biological Transport; Boronic Acids; Cell Movement; DNA; Drug Carriers; GC Rich Sequence; Genetic Therapy; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Microtubules; Nanoparticles; Neoplasm Invasiveness; Polyamines; Tissue Distribution | 2019 |
ATP-Responsive and Near-Infrared-Emissive Nanocarriers for Anticancer Drug Delivery and Real-Time Imaging.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Boronic Acids; Doxorubicin; Drug Carriers; Hep G2 Cells; Humans; Liver Neoplasms; Nanoparticles; Optical Imaging; Theranostic Nanomedicine | 2016 |